3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
132
OTHER
105
NIH
18
NETWORK
3
FED
2
UNKNOWN
1
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Lung Neoplasms
9
Small Cell Lung Carcinoma
8
Brain Neoplasms
3
Neoplasms
2
Urinary Bladder Neoplasms
1
Tuberculosis
1
Thymoma
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Solitary Pulmonary Nodule
1
Sarcoidosis
1
Pneumothorax
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Multiple Pulmonary Nodules
1
Mesothelioma, Malignant
1
Melanoma
1
Lung Diseases, Interstitial
1
Esophageal Neoplasms
1
Cough
1
Colorectal Neoplasms
1
Carcinoma, Small Cell
1
Carcinoma
1
Cancer Pain
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Urinary Bladder Neoplasms
×
Thoracic
×
Clear all
NCT02346955
2020-08-27
MK-6018-001
KitovPharma
Phase 1
Terminated
27 enrolled